Help & Support

According to the EU Regulation 2017/745 (MDR) Chapter I, Article 2/1, a medical device is an instrument, apparatus, appliance, software, implant, reagent, material or other article which, according to the manufacturer, is intended for human use and which, alone or in combination, is intended to fulfill one or more of the following specific medical purposes: Diagnosis, prevention, monitoring, prediction, prognosis, treatment or alleviation of disease, diagnosis, monitoring, treatment, alleviation of or compensation for injury or disability, examination, replacement or modification of anatomy or of a physiologic or pathologic process or condition, obtaining information by the in vitro examination of specimens derived from the human body, including organ, blood and tissue donations, and whose principal intended action in or on the human body is not achieved by pharmacological, immunological or metabolic means, but whose mode of action may be enhanced by such means.

Yes, the protection of personal data during data processing is important to medaia GmbH as the entity responsible for data processing.

For this reason, medaia GmbH complies with all provisions of the General Data Protection Regulation (GDPR) and the Data Protection Act (DSG) when using personal data and strives for the best possible transparency. medaia GmbH processes personal data in accordance with the principles of lawfulness, good faith, transparency, accuracy, purpose limitation, data minimization and storage duration limitation.

SkinScreener’s risk assessment is based on a clinically validated algorithm that was developed and tested in collaboration with the Medical University of Graz. The algorithm works with a neural network that uses artificial intelligence to ensure a risk assessment with an accuracy of 95%.

You need the following to be able to use the app:

iOS:

- Operating System: Version 16.0 or later
- Hardware: iPhone 8 or later

Android:

- Operating system - Android 12 or later
- Hardware: 2.8 GB of RAM

We do further reserve the right to exclude certain devices from downloading the application from the Google Play Store (e.g. Xiaomi, Huawei devices).

‍

SkinScreener is a Class IIa medical device and complies with the requirements of EU Regulation 2017/745 (MDR). To ensure the highest possible technical and medical safety, our team of doctors and technicians is constantly working to secure and further develop our quality management system, which involves high costs. SkinScreener's risk assessment allows you to initiate appropriate medical treatment at an early stage and reduce the progression of skin cancer and its precursors. The first scan is free, so you can download and test the app. If you want to perform more scans, you can choose a subscription model that best suits your needs or buy single scans.

Yes. SkinScreener was developed and clinically tested by a team of dermatologists, physicians, and biomedical engineers. SkinScreener is a Class IIa medical device and complies with the requirements of EU Regulation 2017/745 (MDR). A clinical study conducted at the Medical University of Graz (with more than 600 images from real patients) has proven that SkinScreener has an impressive accuracy rate of 95% in detecting skin cancer. We recommend that you read the instructions for use thoroughly before using the device for the first time.

In the App, you are asked to take a photo of the designated skin area with the camera of your smartphone. The image is then run through our clinically proven neural network. You immediately receive the result. The risk assessment for skin cancer is indicated by an easy to understand 3 color code (low, medium, high risk). Green means low risk, yellow means medium risk, and red means high risk.

We monitored that the incidence of skin cancer has increased steadily worldwide in recent years. Statistically, the probability of developing skin cancer once in a lifetime is about 20%. The earlier skin cancer can be detected, the better are the chances of recovery. This is why we, with all our expertise from medical and technical backgrounds, have developed SkinScreener. We wanted to offer a smart way to determine the personal risk of altered skin areas with an App.

One in five people develop skin cancer. Skin cancer and its preliminary stages are visible and palpable. Therefore, regular self-examinations can help you discover early on where new skin changes have appeared or existing moles have grown. The earlier skin cancer is detected, the higher are the chances of recovery.

If your scan result shows a LOW RISK, we advise to monitor the spot on your skin regularly and rescan it at least once a month. If your scan result shows a MEDIUM RISK or HIGH RISK rating, it means you should see your dermatologist as soon as possible and earlier than the recommended dermatological examinations. The specialist will then verify the results by further specialist examinations.

If your scan result shows a HIGH RISK rating, it means you should see your dermatologist as soon as possible. The specialist will then verify the results by further specialist examinations.

No. SkinScreener is not a substitute for a medical diagnosis. It supports early detection but cannot replace a physical examination or expert opinion. If the app flags a suspicious spot, consult a dermatologist.

Yes. SkinScreener is an ideal tool for corporate health initiatives and preventive screening programs. It can be integrated into employee wellness strategies to support early detection and awareness.

Yes. You can save or screenshot your scan results and show them to your doctor. This can be a helpful first step in prioritizing which moles need medical attention.

If you have any questions, please contact us by email at support@medaia.atlassian.net.

A skin lesion is an area of skin that has abnormal growth or appearance compared to the surrounding skin. In medicine, the term “lesion” usually refers to all types of skin changes and skin damage.

‍

Since skin spots develop over time, it is important to keep an eye on them. When using SkinScreener, be aware that gradual changes in shape, size, or color can lead to a new risk assessment.

Almost anyone can use SkinScreener. The app is intended for adult users with Fitzpatrick skin types I (ivory) to IV (light brown). SkinScreener should not be used on children.

Adults (18 years and older) with Fitzpatrick skin types I–IV (from ivory to light brown) can use SkinScreener. It is not suitable for children or users with skin types V–VI.

‍

Even with Low Risk results, continue to monitor your skin and attend regular check-ups. For Medium or High Risk results, consult a dermatologist to confirm findings and determine further steps

Try reinstalling the app. If the issue persists, contact support@medaia.atlassian.net

Clean your camera and hold the device 15 cm (6 in) from your skin. Keep it steady until the scan completes

Slight variations can happen due to distance or lighting. Always scan between 10–15 cm, and if results differ, consider the most serious (higher risk) one as valid

SkinScreener can help you monitor your skin and allert you to potentially dangerous moles. However, SkinScreener can not give you a diagnosis. You will need to visit a dermatologist.

SkinScreener is owned and operated by medaia GmbH, with its registered office at Am Eisernen Tor 5/1/12, 8010 Graz, Austria.